Beginning this September, Touro University International (TUI) is offering a new series of four online, distance learning courses leading to a graduate certificate in sharps-injury prevention.
The goal of the program is to provide healthcare workers and other professionals with advanced knowledge, skills and abilities to assist international efforts to eliminate the risk of needlestick and other sharps injuries and subsequent risk to bloodborne infections (e.g., HIV, HBV, HCV).
The graduate certificate is designed for public health professionals, infection control and occupational/employee health professionals, environmental, health and safety professionals, education and training staff, laboratorians, nurses and other allied health professionals that need continuing education credits, individuals who want to change or advance in their careers, representatives of companies who manufacture and distribute sharps safety devices, researchers and device inventors.
For more information, visit: http://www.tourou.edu/chs/sharps_injury.htm or call (800) 375-9878.
Source: Touro University International
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.